Life-dependent Home Mechanical Ventilation
Launched by RIGSHOSPITALET, DENMARK · Nov 21, 2023
Trial Information
Current as of November 07, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This is an observational study in Denmark that aims to understand life with life-dependent home mechanical ventilation (HMV). It looks at how it works when a trained respiratory patient caregiver (tPCG) supervises the ventilation at home, whether it’s done invasively through a tracheostomy or non-invasively with a mask. The researchers want to learn about the real-life experiences and challenges from patients, their families, and the caregivers, not to test a new treatment.
Who can participate and what you would do: adults 18 years and older who are on HMV and have a trained caregiver (and their relatives plus the caregiver) in the Respiratory Center East in Denmark are eligible. About 200 people are planned to be enrolled, and participation is by invitation. The main thing researchers will measure is a questionnaire about how severe respiratory problems feel for the patient, asked within the last week. The study is led by Rigshospitalet in Copenhagen, at the Department of Anaesthesia, Pain and Respiratory Support.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient Age \> 18 years Has trained patient care givers to surveil the respiratory treatment and working on the responsibility of the Respiratory Center East
- • Parent Age \> 18 years Has a child less than 18 years old with tPCG, working on the responsibility of the Respiratory Center East, to surveil the home-mechanical ventilation
- Other relative:
- • Age \> 18 years Involved in the treatment or support of a relative with tPCG, working on the responsibility of the Respiratory Center East, to surveil the home-mechanical ventilation
- • Trained patient caregivers (tPCG) Age \> 18 years Employed by an external agency or by the patient (BPA) to surveil home-mechanical ventilation Certified as tPCG working on the responsibility of the Respiratory Center East
- Exclusion Criteria:
- • No informed consent to participate
About Rigshospitalet, Denmark
Rigshospitalet, located in Copenhagen, Denmark, is one of the leading hospitals in Scandinavia and a prominent center for clinical research and innovation. As a key academic institution affiliated with the University of Copenhagen, Rigshospitalet is dedicated to advancing healthcare through rigorous clinical trials and groundbreaking research across various medical disciplines. The hospital’s commitment to excellence is reflected in its multidisciplinary approach, collaboration with international research networks, and focus on improving patient outcomes through evidence-based practices. With state-of-the-art facilities and a team of highly qualified professionals, Rigshospitalet plays a crucial role in translating scientific discoveries into effective treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Glostrup, Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported